For the Week of August 31, 2015
In its quarterly update to the outpatient PPS, did CMS add pass-through status for any new drugs?
Effective July 1, 2015, the following three drugs and biologicals below have pass-through status under the hospital outpatient prospective payment system (OPPS).
|C9453||Injection, nivolumab, 1 mg|
|C9454||Injection, pasireotide long acting, 1 mg|
|C9455||Injection, siltuximab, 10 mg|
To view and archive of the Pharmacy Compliance Question of the Week, click here